Multi-MeMo (“Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia”) is a European funded project that focuses on brain health in older people, overall, and tailored, multidomain interventions (i.e., targeting multiple risk factors simultaneously) for the risk-reduction of cognitive impairment and dementia, in particular. On 27 November, 5 members of the Multi-MeMo Advisory Board (AB) gathered for an online meeting. The Advisory Board brings together members of the public, both with and without cognitive impairment. The meeting was facilitated by Sarah Campill (Alzheimer Europe), who was joined by Cindy Birck (Alzheimer Europe) and Mariagnese Barbera (University of Eastern Finland). A central focus of the session was the development of a video explaining the European medication pathway, following valuable feedback from a previous Advisory Board meeting. A first draft of the video was presented, and attendees were invited to share their views on the content, clarity and format. Members discussed how best to present complex information in an accessible way, and highlighted areas for improvement. The meeting concluded with warm Christmas wishes for the end of the year, reflecting the positive atmosphere of the group. For further information about Multi-MeMo, please visit the project’s website: https://www.multi-memo.eu/
Multi-MeMo is an EU Joint Programme – Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND – www.jpnd.eu: Finland, Research Council of Finland; Germany, Federal Ministry of Education and Research; Luxembourg, National Research Fund; Netherlands, The Netherlands Organisation for Health Research and Development; Slovakia, Ministry of Education, Science, Research and Sport of the Slovak Republic; Spain, National Institute of Health Carlos III.
